135 related articles for article (PubMed ID: 35195030)
1. Copy number alteration signatures as biomarkers in cancer: a review.
Giles Doran C; Pennington SR
Biomark Med; 2022 Apr; 16(5):371-386. PubMed ID: 35195030
[TBL] [Abstract][Full Text] [Related]
2. CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications.
Franch-Expósito S; Bassaganyas L; Vila-Casadesús M; Hernández-Illán E; Esteban-Fabró R; Díaz-Gay M; Lozano JJ; Castells A; Llovet JM; Castellví-Bel S; Camps J
Elife; 2020 Jan; 9():. PubMed ID: 31939734
[TBL] [Abstract][Full Text] [Related]
3. Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing.
Baslan T; Kendall J; Volyanskyy K; McNamara K; Cox H; D'Italia S; Ambrosio F; Riggs M; Rodgers L; Leotta A; Song J; Mao Y; Wu J; Shah R; Gularte-Mérida R; Chadalavada K; Nanjangud G; Varadan V; Gordon A; Curtis C; Krasnitz A; Dimitrova N; Harris L; Wigler M; Hicks J
Elife; 2020 May; 9():. PubMed ID: 32401198
[TBL] [Abstract][Full Text] [Related]
4. Genomic copy number alterations as biomarkers for triple negative pregnancy-associated breast cancer.
Suelmann BBM; Rademaker A; van Dooijeweert C; van der Wall E; van Diest PJ; Moelans CB
Cell Oncol (Dordr); 2022 Aug; 45(4):591-600. PubMed ID: 35792986
[TBL] [Abstract][Full Text] [Related]
5. Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes.
Wang S; Li H; Song M; Tao Z; Wu T; He Z; Zhao X; Wu K; Liu XS
PLoS Genet; 2021 May; 17(5):e1009557. PubMed ID: 33945534
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma.
Essers PBM; van der Heijden M; Vossen D; de Roest RH; Leemans CR; Brakenhoff RH; van den Brekel MWM; Bartelink H; Verheij M; Vens C
Int J Cancer; 2020 Sep; 147(6):1732-1739. PubMed ID: 32167160
[TBL] [Abstract][Full Text] [Related]
7. The repertoire of copy number alteration signatures in human cancer.
Tao Z; Wang S; Wu C; Wu T; Zhao X; Ning W; Wang G; Wang J; Chen J; Diao K; Chen F; Liu XS
Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36806386
[TBL] [Abstract][Full Text] [Related]
8. The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples.
Van Paemel R; Vandeputte C; Raman L; Van Thorre J; Willems L; Van Dorpe J; Van Der Linden M; De Wilde J; De Koker A; Menten B; Devalck C; Vicha A; Grega M; Schleiermacher G; Iddir Y; Chicard M; van Zogchel L; Stutterheim J; Lak NSM; Tytgat GAM; Laureys G; Speleman F; De Wilde B; Lammens T; De Preter K; Van Roy N
Eur J Cancer; 2022 Jan; 160():12-23. PubMed ID: 34794856
[TBL] [Abstract][Full Text] [Related]
9. Hierarchical discovery of large-scale and focal copy number alterations in low-coverage cancer genomes.
Khalil AIS; Khyriem C; Chattopadhyay A; Sanyal A
BMC Bioinformatics; 2020 Apr; 21(1):147. PubMed ID: 32299346
[TBL] [Abstract][Full Text] [Related]
10. Specific genomic regions are differentially affected by copy number alterations across distinct cancer types, in aggregated cytogenetic data.
Kumar N; Cai H; von Mering C; Baudis M
PLoS One; 2012; 7(8):e43689. PubMed ID: 22937079
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide somatic copy number alteration analysis and database construction for cervical cancer.
Luo H; Xu X; Yang J; Wang K; Wang C; Yang P; Cai H
Mol Genet Genomics; 2020 May; 295(3):765-773. PubMed ID: 31901979
[TBL] [Abstract][Full Text] [Related]
12. Genomic and prognostic heterogeneity among RAS/BRAF
Berg KCG; Brunsell TH; Sveen A; Alagaratnam S; Bjørnslett M; Hektoen M; Brudvik KW; Røsok BI; Bjørnbeth BA; Nesbakken A; Lothe RA
Mol Oncol; 2021 Apr; 15(4):830-845. PubMed ID: 33325154
[TBL] [Abstract][Full Text] [Related]
13. Copy-number analysis identified new prognostic marker in acute myeloid leukemia.
Nibourel O; Guihard S; Roumier C; Pottier N; Terre C; Paquet A; Peyrouze P; Geffroy S; Quentin S; Alberdi A; Abdelali RB; Renneville A; Demay C; Celli-Lebras K; Barbry P; Quesnel B; Castaigne S; Dombret H; Soulier J; Preudhomme C; Cheok MH
Leukemia; 2017 Mar; 31(3):555-564. PubMed ID: 27686867
[TBL] [Abstract][Full Text] [Related]
14. Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer.
Staaf J; Jönsson G; Ringnér M; Baldetorp B; Borg A
Breast Cancer Res; 2011; 13(6):R129. PubMed ID: 22169037
[TBL] [Abstract][Full Text] [Related]
15. Identification of driver genes regulating immune cell infiltration in cervical cancer by multiple omics integration.
Wen Y; Zhang S; Yang J; Guo D
Biomed Pharmacother; 2019 Dec; 120():109546. PubMed ID: 31675687
[TBL] [Abstract][Full Text] [Related]
16. Pan-cancer driver copy number alterations identified by joint expression/CNA data analysis.
Wang G; Anastassiou D
Sci Rep; 2020 Oct; 10(1):17199. PubMed ID: 33057153
[TBL] [Abstract][Full Text] [Related]
17. Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis.
Thiesen HJ; Steinbeck F; Maruschke M; Koczan D; Ziems B; Hakenberg OW
PLoS One; 2017; 12(5):e0176659. PubMed ID: 28486536
[TBL] [Abstract][Full Text] [Related]
18. Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death.
Hieronymus H; Murali R; Tin A; Yadav K; Abida W; Moller H; Berney D; Scher H; Carver B; Scardino P; Schultz N; Taylor B; Vickers A; Cuzick J; Sawyers CL
Elife; 2018 Sep; 7():. PubMed ID: 30178746
[TBL] [Abstract][Full Text] [Related]
19. Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressures.
Graham NA; Minasyan A; Lomova A; Cass A; Balanis NG; Friedman M; Chan S; Zhao S; Delgado A; Go J; Beck L; Hurtz C; Ng C; Qiao R; Ten Hoeve J; Palaskas N; Wu H; Müschen M; Multani AS; Port E; Larson SM; Schultz N; Braas D; Christofk HR; Mellinghoff IK; Graeber TG
Mol Syst Biol; 2017 Feb; 13(2):914. PubMed ID: 28202506
[TBL] [Abstract][Full Text] [Related]
20. Identification of Novel Breast Cancer Subtype-Specific Biomarkers by Integrating Genomics Analysis of DNA Copy Number Aberrations and miRNA-mRNA Dual Expression Profiling.
Li D; Xia H; Li ZY; Hua L; Li L
Biomed Res Int; 2015; 2015():746970. PubMed ID: 25961039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
